medtronic adbs - Search News

Medtronic, Parkinson's disease and U.S. FDA

A Medtronic engineer shares lessons from the adaptive deep brain stimulation project

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott Stanslaski said.

Benzinga.com · 1d

FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.

PharmiWeb · 4h

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration (FDA) approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™

Medscape23h

FDA OKs First Adaptive DBS System for Parkinson’s Disease

The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...

21don MSN

Medtronic’s CEO says, “We’ve got to be an ‘and’ company”

Earlier this year, Medtronic received approval from European regulators for its adaptive deep brain stimulation (aDBS) technology, which includes an implant that can dynamically adjust signals to ...

News Medical on MSN7h

A new treatment can adjust to Parkinson's symptoms in real time

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Medtronic, Parkinson's disease and U.S. FDA

Trending now

Related topics